A4R...you do understand that the entire oncology arena is shifting to IO right? Monoclonal Antibodies....The Sunrise Trial is a victim of many things including the worst timing to get it going.....
Checkmate? Riiiiggghhhttttttttt.
Not only IO but IO combos.....so many docs investigating the MOA of Bavituximab and interested in combos.....well see what the PPer has to say tomorrow....
Market Data 
Markets 
AI
